The 2025 ICE-T Symposium highlighted expansion beyond BCMA to additional targets such as GPRC5D and FcRH5.
Carmel Awadallah, MD
Advertisement
Articles by Carmel Awadallah, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma
2
Iza-Bren Yields Encouraging Activity in Extensive-Stage SCLC
3
How AI and Health Networks Are Democratizing Clinical Trial Access
4
Zipalertinib Combo Meets PFS End Point in First-Line EGFR Exon 20 NSCLC
5